Implications of +647 A/C MT1A polymorphism in type 2 diabetes;Implicazione del polimorfismo +647 A/C del gene MT1A nel diabete mellito di tipo 2

Giornale di Gerontologia

Volumn 57, Issue 4, 2009, Pages 189-193

  Giacconi, Robertina ^a   Bonfigli, A R ^a   Testa, R ^a   Sirolla, C ^a   Cipriano, C ^a   Marra, M ^a   Malavolta, M ^a   Lattanzio, F ^a   Mocchegiani, E ^a  

^a INRCA   (Italy)

Author keywords

Metallothionein polymorphism; Type 2 diabetes; Zinc

Indexed keywords

HEMOGLOBIN A1C; METALLOTHIONEIN I; ZINC BINDING PROTEIN; ZINC ION;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FLOW CYTOMETRY; GENETIC POLYMORPHISM; GENOTYPE; GLYCEMIC CONTROL; HUMAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; STATISTICAL ANALYSIS; ZINC BLOOD LEVEL;

EID: 75649113720     PISSN: 00170305     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Stirban A, Negrean M, Stratmann B, Gawlowski T, Horstmann T, Götting C, et al. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 2006;29:2064-71.
2. Maret W, Krezel A. Cellular Zinc and Redox Buffering Capacity of Metallothionein/Thionein in Health and Disease. Mol Med 2007;13:371-5.
3. Reunanen A, Knekt P, Marniemi J, Mäki J, Maatela J, Aromaa A. Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur J Clin Nutr 1996;50:431-7.
4. Beletate V, El Dib R, Atallah A. Zinc supplementation for the prevention of type 2 diabetes mellitus. Cochrane Database Syst Rev 2007;24:CD005525.
5. Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X, et al. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol 2006;48:1688-97.
6. Giacconi R, Caruso C, Malavolta M, Lio D, Balistreri CR, Scola L, et al. Pro-inflammatory genetic background and zinc status in old atherosclerotic subjects. Ageing Res Rev 2008;7:306-18.
7. Giacconi R, Cipriano C, Muti E, Costarelli L, Maurizio C, Saba V, et al. Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology 2005;6:407-13.
8. Cipriano C, Malavolta M, Costarelli L, Giacconi R, Muti E, Gasparini N, et al. Polymorphisms in MT1a gene coding region are associated with longevity in Italian Central female population. Biogerontology 2006;7:357-65.
9. West IC. Radicals and oxidative stress in diabetes. Diabet Med 2000;17:171-80.
10. Al-Maroof RA, Al-Sharbatti SS. Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics. Saudi Med J 2006;27:344-350.
11. Gunduz G, Gunduz F, Yucel I, Senturk UK. Levels of zinc and magnesium in senile and diabetic senile cataractous lenses. Biol Trace Elem Res 2003;95:107-11.